Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy Evaluation of Hydroxychloroquine Azithromycin in the Treatment of COVID-19 in Pregnant Women: an Open-label Randomized Clinical Trial

NCT04365231 is registered in ClinicalTrials.gov with Hospital St. Joseph, Marseille, France as lead sponsor.

NCT NCT04365231
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04365231 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy Evaluation of Hydroxychloroquine Azithromycin in the Treatment of COVID-19 in Pregnant Women: an Open-label Randomized Clinical Trial
Lead sponsor
Hospital St. Joseph, Marseille, France
Phase
Phase 3
Overall status
Withdrawn
Start date
April 1, 2020
Completion date
April 1, 2021
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

covid19